Similarly, enhanced bone formation was observed in MP2 tumor-bearing mice treated with a combination of sNK cell injections and AJ2 consumption, compared to untreated MP2 tumor-bearing mice (Figure 4A). The gene discussed is PLK2; the disease is neoplasm.